Liquidia (LQDA) Change in Accured Expenses (2020 - 2026)

Liquidia's (LQDA) quarterly Change in Accured Expenses came in at $14.5 million in Q1 2026, up 401.62% year-on-year from $2.9 million in Q1 2025, and down 55.63% quarter-over-quarter from $32.8 million in Q4 2025.

Liquidia (LQDA) Change in Accured Expenses (2020 - 2026) Analysis & Trends

Liquidia's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $14.5 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 401.62% year-over-year to $14.5 million in Q1 2026; TTM through Mar 2026 was $73.9 million, a 32649.78% increase from a year earlier, with the FY2025 full-year figure at $54.5 million, up 937.04% from the prior year.
  • Change in Accured Expenses fell to $14.5 million in Q1 2026 per LQDA's latest filing, from $32.8 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $32.8 million in Q4 2025 and bottomed at -$4.8 million in Q1 2025.
  • The 5-year median for Change in Accured Expenses is $1.8 million (2023), against an average of $4.9 million.
  • Biggest YoY gain for Change in Accured Expenses was 1913.33% in 2023; the steepest drop was 3781.43% in 2023.
  • Year by year, Change in Accured Expenses stood at $330000.0 in 2022, then surged by 1913.33% to $6.6 million in 2023, then sank by 70.38% to $2.0 million in 2024, then soared by 1564.28% to $32.8 million in 2025, then sank by 55.63% to $14.5 million in 2026.
  • Per Business Quant, the three latest LQDA Change in Accured Expenses figures stand at $14.5 million (Q1 2026), $32.8 million (Q4 2025), and $17.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -144.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -12.70 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Liquidia 7.84 Bn 7.61 Bn 121.79 Mn 14.53 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 14.53 Mn
Mar 31, 2026 14.53 Mn
Dec 31, 2025 32.75 Mn
Dec 31, 2025 32.75 Mn
Sep 30, 2025 17.92 Mn
Sep 30, 2025 17.92 Mn
Jun 30, 2025 8.68 Mn
Jun 30, 2025 8.68 Mn
Mar 31, 2025 -4.82 Mn
Mar 31, 2025 -4.82 Mn
Dec 31, 2024 1.97 Mn
Dec 31, 2024 1.97 Mn
Sep 30, 2024 3.59 Mn
Sep 30, 2024 3.59 Mn
Jun 30, 2024 -968,000.00
Jun 30, 2024 -968,000.00
Mar 31, 2024 668,000.00
Mar 31, 2024 668,000.00
Dec 31, 2023 6.64 Mn
Dec 31, 2023 6.64 Mn